Decreased recovery of CD4 lymphocytes in older HIV-infected patients beginning highly active antiretroviral therapy

AIDS

Volumn 15, Issue 12, 2001, Pages 1576-1579

  Goetz, Matthew Bidwell ^a   Boscardin, W John ^b   Wiley, Dorothy ^b   Alkasspooles, Salam ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ADULT; AGE; AGED; ANTIVIRAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MODEL; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS LOAD;

AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; AREA UNDER CURVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED;

EID: 0035903006     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200108170-00017     Document Type: Article

References (17)

1. CD4+ cell count is a better predictor of disease progression than HIV RNA level in persons with advanced HIV infection on highly active antiretroviral therapy
2. Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor
3. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease
4. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: A prospective cohort study
5. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: The Swiss HIV cohort study
6. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy
7. The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection
8. Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen
9. Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy
10. Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: Age inversely predicts naive CD4 cell count increase
11. Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter
12. Changes in thymic function with age and during the treatment of HIV infection
13. Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults
14. Human immunodeficiency virus type 1 infection: Relationship of risk group and age to rate of progression to AIDS
15. Survival after introduction of HAART in people with known duration of HIV-1 infection
16. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: A collaborative re-analysis